Cato BioVentures

Cato BioVentures

Cato BioVentures

Overview
Date Founded

1988

Headquarters

Bay Colony Corporate Center,1100 Winter Street,Waltham, MA 02451-1427

Type of Company

Private

Industries

Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

Cato BioVentures focuses on early-stage investment opportunities in private companies and PIPE opportunities in undervalued public companies in the life sciences sector. They target innovative therapeutics, medical devices, diagnostics and platform tools and technologies for improved drug discovery and development. Cato BioVentures seeks companies with novel therapeutics for central and peripheral nervous system disorders, cardiovascular disease, metabolic disease and cancer, with special emphasis on next generation embryonic stem cell-based technologies and skin penetration enhancement delivery systems. Cato BioVentures also seeks product development opportunities in public companies that have gone off track or fallen out of favor with the investment community. The firm's strategic services often serve as a bridge during the period between a company's formation or initial angel financing and its first institutional financing.Cato BioVentures often co-invests with other institutional investors and they generally do not require a board seat as a condition of their investment. In a board-like manner, the firm's principals regularly provide essential market, regulatory and drug development insights, as well as financial, operational and strategic advice.Cato seeks to invest in companies with a realistic business model built on reasonable assumptions, innovative drug candidates or technologies supported by a strong intellectual property position and a solid pathway to commercial protection. They prefer companies targeting a large market potential (at least $100 million in annual sales) within a reasonable amount of time (up to seven years) based upon a realistic analysis of the market from the bottom up.

Contact Data
Trying to get in touch with decision makers at Cato BioVentures? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

Co-Founder

Chief Legal Officer

Principal

Vice President

Vice President

Strategic Business Developer

Strategic Business Developer

Strategic Business Developer

Medical Analyst

Paths to Cato BioVentures
Potential Connections via
Relationship Science
You
Cato BioVentures
Recent Transactions
Details Hidden

Relief Therapeutics Holding AG purchases FirstString Research, Inc. from Cato BioVentures

Details Hidden

Kerry Group Plc purchases Biothera, Inc. /Wellmune Business from Biothera, Inc., Cato BioVentures

Investments
Details Hidden

InnerOptic Technology, Inc. develops real-time visualization systems. Its services include integration, contract development, and patent licensing. The firm specializes in laparoscopy and laparoscopic ultrasound, image-guided surgery, medical visualization, real-time tracking and spatial coordination, 3D navigation, and human perception, factors, and computer interaction. The company was founded by Kurtis P. Keller, Sheila A. Mikhail, Andrei State, and Henry Fuchs in 2003 and is headquartered in Hillsborough, NC.

Details Hidden

Cancer Advances, Inc. develops treatment of gastrointestinal cancers. It also develops variety of immunomodulators which includes adaptive T-cells, therapeutic vaccines, and monoclonal antibodies for the treatment of gastric and pancreatic cancer. The company was founded in 2008 and is headquartered in Durham, NC.

Details Hidden

Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm's DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cato BioVentures. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cato BioVentures's profile does not indicate a business or promotional relationship of any kind between RelSci and Cato BioVentures.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/cato-bioventures-820366
  • https://relationshipscience.com/organization/cato-bioventures-820366